Detection of a Platelet-Agglutinating Factor in Thrombotic Thrombocytopenic Purpura
- 1 November 1984
- journal article
- research article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 101 (5), 589-593
- https://doi.org/10.7326/0003-4819-101-5-589
Abstract
A sensitive and specific test was used to identify a platelet-agglutinating factor in sera from patients with thrombotic thrombocytopenic purpura. Serum from patients plus a preparation rich in large multimers of factor VIII: von Willebrand factor were added to target platelets, and agglutination occurred in 41 of 48 samples. Edetic acid, heparin or heating, but not aspirin, monometic IgG or dansylarginine N-(3-ethyl-1,5-pentanediyl) amide inhibited the platelet-agglutinating factor. In-vitro agglutination requires the presence of a platelet-agglutinating factor and large multimers of von Willebrand factor. High concentrations of either component lowers the amount of the other required for platelet agglutination. Some patients may be more susceptible to the agglutinating factor because of a congenital or acquired abnormality in processing unusually large multimers of von Willebrand factor, or because of infections or inflammatory disoders that lead to increased synthesis of large multimers of von Willebrand factor.Keywords
This publication has 9 references indexed in Scilit:
- The Measurement of Plateiet-Associated IgG Using an Immunoradiometric AssayJournal of Immunoassay, 1983
- Altered Factor VIII in Acute Respiratory FailureNew England Journal of Medicine, 1982
- MULTIMERIC STRUCTURE OF PLATELET FACTOR-VIII VONWILLEBRAND-FACTOR - THE PRESENCE OF LARGER MULTIMERS AND THEIR REASSOCIATION WITH THROMBIN-STIMULATED PLATELETS1982
- MULTIMERIC COMPOSITION OF FACTOR-VIII VONWILLEBRAND-FACTOR FOLLOWING ADMINISTRATION OF DDAVP - IMPLICATIONS FOR PATHO-PHYSIOLOGY AND THERAPY OF VONWILLEBRANDS DISEASE SUBTYPES1982
- ELEVATED PLATELET-BOUND IGG ASSOCIATED WITH AN EPISODE OF THROMBOTIC THROMBOCYTOPENIC PURPURA1981
- Interactions of a fluorescent active-site-directed inhibitor of thrombin: dansylarginine N-(3-ethyl-1,5-pentanediyl)amideBiochemistry, 1979
- DIRECT ASSAY FOR PLATELET-ASSOCIATED IGG (PAIGG) - LACK OF ASSOCIATION BETWEEN ANTIBODY LEVEL AND PLATELET SIZE1979
- PRESENCE OF A PLATELET AGGREGATING FACTOR IN THE PLASMA OF PATIENTS WITH THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) AND ITS INHIBITION BY NORMAL PLASMA1979
- Studies on apyrasesArchives of Biochemistry and Biophysics, 1961